Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 The Large Amendment to Polands Reimbursement Act- Disappointing but Not Disastrous 11-02-2023
Novartis' CML Blockbuster Drug Tasigna Faces US Patent Expiry in January 2024 11-03-2023
Contract Pharmaceutical Dose Manufacturing Industry Composition, Size, Market Share, and Outlook – 2023 Edition 11-08-2023
Strong Phase III Results for Retevmo Reinforce its Use in RET-mutant MTC and NSCLC 11-10-2023
FDA Approves Takeda’s Targeted Therapy for Advanced Colon Cancer 11-10-2023
October Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q4 2023 11-13-2023
AstraZeneca Announces New Oral GLP-1 Combination to Address Obesity and Comorbidities 11-13-2023
FDA Oversees Rise in Awarded Orphan Drug Designations for Myelofibrosis 11-13-2023
FDA Approval of Valneva’s IXCHIQ Brings World’s First Chikungunya Vaccine to Market 11-15-2023
질환별 Diabetes Demystified A Spotlight on Awareness and Epidemiology 11-06-2023
Myasthenia Gravis Market to Generate Sales of $6.7 Billion by 2032 11-08-2023
Heart Failure: 68-Market Analysis and Sales Forecast 11-09-2023
Crohn’s Disease 68-Market Analysis and Sales Forecast 11-10-2023
Colon and Rectal Cancer Symptoms Should Not be Ignored 11-16-2023
Dengue Fever Could Become Epidemic in Europe as Temperatures Soar 11-16-2023
컨퍼런스/
심포지엄/학회
ESMO 2023: Pluvicto Sees Survival Hurdle in mCRPC in Novartis’s Latest Radiopharmaceutical Expansion 11-02-2023
AAO 2023: Apellis Pharmaceuticals Reveals GALE Extension Study Results for Syfovre 11-06-2023
AAO 2023: PULSAR and PHOTON Studies Provide Promising Results for AMD and DME 11-06-2023
AAO 2023: Allgenesis Biotherapeutics Presents Phase IIa Data of AG-73305 for DME 11-07-2023
AAO 2023: Phase II ALTITUDE Study Provides Promising Results for ABBV-RGX-314 11-08-2023

 

Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 Keytruda Wins Second Place in the Race to Approval for Neo-adjuvant NSCLC 10-20-2023
Manufacturing Issues Delay Lebrikizumab’s Entry to the Atopic Dermatitis Market 10-23-2023
Pear Therapeutics: A Lesson for Future DTx Developers 10-23-2023
Opdivo’s Additional FDA Nod Continues the Battle of Immune Checkpoint Inhibitors 10-23-2023
AnapstysBio’s Imsidolimab Phase III Trial’s Promising Results Can Bring it Closer to Marketing Approval 10-25-2023
Venture Financing for Targeted Protein Degraders Soars in 2022 10-27-2023
North America Leads Dose Response Trials 10-30-2023
Upcoming Breast Cancer Trials in China 10-31-2023
Tibsovo Unlocks a New Era for Rare Blood Cancers Called Myelodysplastic Syndromes 10-31-2023
US Meningococcal Vaccines Market to Begin to Shift Towards Pentavalent Vaccines 11-02-2023
질환별 Neuronopathic Therapies Are a Serious Unmet Need in the Treatment of Gaucher Disease 10-18-2023
Red Meat Consumption Linked to Elevated Type 2 Diabetes Rate 10-23-2023
Antimicrobial Resistance Threatens to Set Modern Medicine Back Decades 10-24-2023
Finding the Crohn’s Disease Leader Is Underway with the Anti-Interleukin 23s 10-25-2023
Myasthenia Gravis: Opportunity Assessment and Forecast 10-31-2023
컨퍼런스/
심포지엄/학회
ESMO 2023: Mirati’s Krazati and Immuno-oncology Combination to Shape KRAS-mutated First-Line NSCLC Landscape 10-23-2023
ESMO 2023: MSD’s Welireg Sets the Stage for HIF-2alpha Inhibitors in Clear Cell RCC Despite Unclear OS 10-23-2023
ESMO 2023: Astellas’s Padcev Combo Disrupts Urothelial Cancer Landscape with EV-302 Results 11-02-2023
Highlights from the ESMO 2023 Congress: Antibody-Drug Conjugates and Bispecific T-cell Engagers 11-02-2023

 

Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/
임상시험
Biologics Emerge as Dominating Molecule Type in Solid Tumor Indication 10-04-2023
Can Gilead Shake Up the ASCT-Ineligible Large B-Cell Lymphoma Market? 10-05-2023
Semaglutide: A Price and HTA Comparison Between the US and Top European Markets 10-05-2023
FDA Questions Efficacy of Amgen's Lumakras in Pivotal Lung Cancer Trial, Citing Bias Concerns 10-10-2023
Bristol Myers Squibb Expands Oncology Portfolio with Mirati Acquisition 10-13-2023
Potential FDA Approval for Supernus’s SPN-830 in Parkinson’s but Challenges Remain 10-13-2023
Patient Comfort in AI-Driven Healthcare Is Linked to Familiarity with Technology 10-13-2023
Novo Nordisk Stops Trial of Ozempic in Kidneys as Interim Analysis Shows Success 10-17-2023
Lack of In-Person Interaction Is the Main Patient Concern Associated with Physicians Using AI in Clinical Practice 10-17-2023
질환별 Early Detection Matters: The Role of Mammograms in Breast Cancer Survival 10-03-2023
Seasonal Influenza Vaccines Epidemiology Forecast to 2032 10-05-2023
Non-Alcoholic Steatohepatitis (NASH): Epidemiology Forecast to 2032 10-06-2023
Crohn’s Disease Eight-Market Drug Forecast and Market Analysis to 2032 10-06-2023
Acute Renal Failure Competitive Landscape 10-09-2023
Dravet Syndrome Competitive Landscape 10-09-2023
Heart Failure Market Estimated to Grow at Rate of 5.2%, Driven by Pipeline Agents Aimed at Unmet Needs 10-12-2023
Heart Failure Seven-Market Drug Forecast and Market Analysis 10-12-2023
Metachromatic Leukodystrophy: Competitive Landscape 10-15-2023
Air Pollution Is Increasing Risk of Postmenopausal Osteoporosis 10-16-2023
Lennox-Gastaut Syndrome: Competitive Landscape 10-19-2023
Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 Promise for Relmada Therapeutics’s Antidepressant REL-1017, But More Data Required 09-25-2023
Generics Expected to Improve Access for Patients with Idiopathic Pulmonary Fibrosis 09-25-2023
Are Decentralized Clinical Trials Actually Patient-Centric? 09-26-2023
Small-Cap Companies Lead the Oncology Pipeline by Programs in Development 09-28-2023
Could Gene Therapy Capacity Crunch Be Solved by Switch to Non-Viral Transfection? 09-29-2023
Can Manufacturing Reforms Restore Faith in India’s Pharma Industry After Cough Syrup Scandals? 09-29-2023
Phase III Results Boost Datopotomab Deruxtecan’s Potential in Breast Cancer 09-29-2023
Antibody Drug Conjugates dominate with Billion-Dollar Licensing Agreements in 2022 09-29-2023
Approval of Eisai’s Leqembi Brings First Anti-amyloid Treatment to the Japanese Market 10-02-2023
Bio/Pharmaceutical Outsourcing Report, September 2023 10-03-2023
Biologics Emerge as Dominating Molecule Type in Solid Tumor Indication 10-04-2023
질환별 Systemic Lupus Erythematosus and Lupus Nephritis 68-Market Analysis and Sales Forecast 09-28-2023
Acute Myeloid Leukemia (AML): Opportunity Assessment and Forecast 09-29-2023
Batten Disease: Competitive Landscape 09-29-2023
Chronic Lymphocytic Leukemia: Opportunity Assessment and Forecast 09-29-2023
Limited Innovation in the Late-Stage Pipeline for Insomnia 09-29-2023
Early Detection Matters The Role of Mammograms in Breast Cancer Survival 10-03-2023
컨퍼런스/심포지엄
/학회
EASD 2023: Meta-Analysis Demonstrates Tirzepatide Superiority to Semaglutide 10-03-2023
EASD 2023: Effectiveness of GLP-1 Agonists vs. DPP-4Is in Patients with T2D and CKD 10-05-2023
EASD 2023: Efficacy of Initial Triple Combination Therapy in Drug-Naïve Patients with T2D 10-09-2023

 

+ Recent posts